Akers Biosciences, Inc. Skyrocketed
Mon, Apr 06, 2020 at 05:30 PM
Akers Biosciences, Inc. (AKER:NASDAQ) shot up at $4.69, a gain of 146.8%. On Fri 03 Apr 20, AKER:NASDAQ hit a New 2-Week Low of $1.9. The stock appeared on our News Catalysts scanner on Mon 06 Apr 20 at 09:48 AM in the 'BIOTECH' category. From Fri 20 Mar 20, the stock recorded 30.00% Up Days and 27.27% Green Days
The stock spiked on Tue 24 Mar 20 at $3.39 with a volume of 5M+, and its share price has been moving sideways in recent weeks.
About Akers Biosciences, Inc. (AKER:NASDAQ)
Akers Biosciences Inc is engaged in the development and sale of disposable diagnostic testing device. The Company develops, manufactures, and supplies rapid, point-of-care screening and testing products.
Top 10 Gainers:
- Akers Biosciences, Inc. (AKER:NASDAQ), 146.84%
- Immunomedics, Inc. (IMMU:NASDAQ), 99.79%
- Exantas Capital Corp. (XAN:NYSE), 57.55%
- Aeterna Zentaris Inc. (AEZS:NASDAQ), 55.72%
- Associated Capital Group, Inc. (AC:NYSE), 48.82%
- Mesoblast Limited (MESO:NASDAQ), 46.67%
- Atossa Therapeutics, Inc. (ATOS:NASDAQ), 44.23%
- Braemar Hotels & Resorts, Inc. (BHR:NYSE), 43.55%
- Pensare Acquisition Corp. (WRLS:NASDAQ), 43.33%
- Cherry Hill Mortgage Investment Corporation (CHMI:NYSE), 41.52%